Transdermal therapeutic system for administering rivastigmine or derivatives thereof

US10076502B2 · kind B2 · utility

Assignee

• Luye Pharma AG · DE

Inventors

• Heike Prinz · Unterhaching, DE
• Björn Schurad · Munich, DE
• Thomas Beckert · Darmstadt, DE
• Kristina Linder · Kiefersfelden, DE

Key dates

• Filing date: Dec 19, 2014
• Grant date: Sep 18, 2018
• Expiry date: Feb 15, 2036

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K31/325
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to a transdermal therapeutic system for administering an active substance through the skin, comprising: